• Are current drug development programmes realising the full potential of new agen...
  Are current drug development programmes realising the full potential of new agents? The scenario.

  Breast Cancer Res. 2009 ;11 Suppl 3:S21. Epub 2009 Dec 18 .
  PubMed
• The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediat...
  The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.

  Breast Cancer Res. 2009 ;11(4):R57. Epub 2009 Aug 6 .
  PubMed
• A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/here...
  A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.

  Cancer Res. 2004 Oct 1 ;64(19):6840-4.
  PubMed
• High-resolution analysis of chromosome rearrangements on 8p in breast, colon and...
  High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation.

  Oncogene. 2006 Sep 14 ;25(41):5693-706. Epub 2006 Apr 24 .
  PubMed
• Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breas...
  Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.

  Breast Cancer Res. 2010 ;12(4):R65. Epub 2010 Aug 27 .
  PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on